Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists Grant US-11878026-B2 United States of America 23 Jan 2024
Heterobifunctional inhibitors of E-selectin and galectin-3 Grant US-11845771-B2 United States of America 19 Dec 2023
Highly potent multimeric e-selectin antagonists Grant US-11780873-B2 United States of America 10 Oct 2023
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof Grant US-11712446-B2 United States of America 01 Aug 2023
Methods for treating acute myeloid leukemia and related conditions Grant US-11707474-B2 United States of America 25 Jul 2023
Heterobifunctional inhibitors of E-selectin and galectin-3 Grant US-11548908-B2 United States of America 10 Jan 2023
Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or… Grant US-11433086-B2 United States of America 06 Sep 2022
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-se… Grant US-11291678-B2 United States of America 05 Apr 2022
Anti-CD33 antibodies and methods of use thereof Grant US-11254743-B2 United States of America 22 Feb 2022
Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists Grant US-11197877-B2 United States of America 14 Dec 2021
Anti-CD33 antibodies and methods of use thereof Grant US-11174313-B2 United States of America 16 Nov 2021
Anti-CD33 antibodies and methods of use thereof Grant US-11136390-B2 United States of America 05 Oct 2021
Highly potent multimeric e-selectin antagonists Grant US-11072625-B2 United States of America 27 Jul 2021
ANTI-CD33 ANTIBODY FOR USE IN TREATING ALZHEIMER'S DISEASE Grant EP-2978446-B1 European Patent Office 04 Mar 2020